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4INDUSTRIAL INJURIES ADVISORY COUNCIL
Secretary of State for Work and Pensions
Dear Secretary of State,
REVIEW OF BRONCHIOLITIS OBLITERANS AND FOOD FLAVOURING 
AGENTS
This report details the Council’s consideration of prescription for bronchiolitis 
obliterans arising from exposure to food fl avouring agents containing 
diacetyl (referred to in early research reports as ‘popcorn worker’s lung’).
Evidence of an association was fi rst brought to our attention in November 
2007 by colleagues from the Health and Safety Executive. We have since 
considered published research on the topic, made a call for evidence and 
consulted with experts in the fi eld, and present our recommendations to you 
within eight months of commencing the review. The expediency with which 
we have completed our report is, in part, due to our wish to raise awareness 
of this uncommon and very harmful respiratory condition so that cases may 
be recognised, where appropriate compensated and ultimately be 
prevented.
A body of evidence is emerging that links exposure to certain food fl avouring 
agents, notably the buttery food fl avouring agent diacetyl, with the 
development of bronchiolitis obliterans. Several cases have been reported in 
the USA and in Europe, including one from the UK, in workers exposed to 
diacetyl-containing food fl avouring agents, used in popcorn and potato crisp 
manufacture, and in the production of diacetyl. The toxic injury this agent 
can cause to the lungs has been confi rmed in animal experiments, which 
add to the epidemiological evidence in human populations. Bronchiolitis 
obliterans is a rare disease, so in affected individuals whose work involves 
exposure to food fl avouring agents containing diacetyl, an occupational 
cause can be strongly presumed.
We recommend that bronchiolitis obliterans arising during work involving the 
production of diacetyl, or the manufacture of food fl avourings containing 
diacetyl, or the manufacture of food fl avoured by diacetyl be added to the 
list of prescribed diseases for which Industrial Injuries Disablement Benefi t is 
payable.
Yours sincerely,
Professor K Palmer 
Chairman
Date: July 2008
5Summary
Bronchiolitis obliterans is an uncommon respiratory disease 1. 
characterised by fi xed airway obstruction, whereby the bronchioles in the 
lung become narrowed or blocked by fi brous tissue. The disease is disabling 
and can be potentially severe, leading to lung transplantation in some 
patients. Bronchiolitis obliterans may be caused occupationally by 
accidental, acute, high concentration exposure to industrial gases, such as 
nitrogen dioxide. 
In November 2007, the Council’s attention was drawn to emerging 2. 
evidence of an association between bronchiolitis obliterans and day to day 
exposure to food fl avouring agents (i.e. not linked with accidental chemical 
exposures). Cases were fi rst identifi ed in workers exposed to food fl avouring 
agents used in popcorn manufacture in the United States, and the disease 
became known as ‘popcorn worker’s lung’. Subsequently, however, cases 
were identifi ed outside popcorn manufacture, in manufacture of the food 
fl avouring agent, diacetyl (also known as butanedione or 2,3-butanedione; 
C4H6O2) , in the Netherlands, and in potato crisp production in the UK. 
Evidence suggests that the causal agent is likely to be diacetyl, an agent 
with a buttery fl avour, or a chemical closely associated with diacetyl usage 
or production.
Following reviews of relevant research, calls for evidence and 3. 
consultations with experts in the fi eld, the Council concludes that a causal 
relationship between bronchiolitis obliterans and exposure to food fl avouring 
agents is likely, and is supported by i) evidence of the clustering of cases of 
this rare disease in several factories where exposures to diacetyl were 
shared in common; ii) the development of fi xed airways obstruction in the 
absence of other explanations (e.g. emphysema); iii) a demonstrated dose-
response relationship between exposure to food fl avouring agents and the 
onset of symptoms and declining lung function, and iv) experiments 
demonstrating pulmonary damage in animals exposed to diacetyl. The 
Council has concluded that there is strong evidence of an association 
between work in diacetyl production or use of diacetyl as a food fl avouring 
agent and the development of bronchiolitis obliterans.
Diagnosis of bronchiolitis obliterans is relatively complicated, based on 4. 
clinical features, lung function tests, chest radiographs and computed 
tomography scans. A feature that distinguishes bronchiolitis obliterans from 
the more chronic condition of bronchitis and emphysema, however, is the 
relatively rapid onset of symptoms (within weeks or months) following 
diacetyl exposure, as compared to the much slower progression of 
symptoms associated with the development of chronic airways disease. 
6In practice, cases presenting for benefi t are likely to have had extensive 
clinical investigations to confi rm diagnosis.
The Council recommends that bronchiolitis obliterans arising during 5. 
work involving production of diacetyl, or the manufacture of food fl avourings 
containing diacetyl, or the manufacture of food fl avoured by diacetyl be 
added to the scheduled list of prescribed diseases for which Industrial 
Injuries Disablement Benefi t is payable. Diagnosis should normally be based 
upon prior hospital investigations, and confi rmatory evidence of diagnosis 
should be sought from the appropriate source(s). 
7INTRODUCTION
Background to this review
In November 2007, Health and Safety Executive offi cials highlighted to 6. 
the Council emerging research literature about workers in North America 
with bronchiolitis obliterans exposed to fl avouring agents used in the food 
processing industry. The term ‘Popcorn worker’s lung’ was coined to 
describe the disease as the clusters of cases reported in North America 
were fi rst described in workers in microwave popcorn processing plants. 
The Council’s enquiries also identifi ed one case of bronchiolitis obliterans in 
the United Kingdom associated with occupational exposure to food 
fl avouring agents used in potato crisp manufacture (Hendrick, 2008).
Method of investigation
IIAC referred the matter of food fl avourings and bronchiolitis obliterans 7. 
to its permanent sub-committee, the Research Working Group, which 
conducted a literature search and reviewed key research papers. The 
Council also consulted with a respiratory expert about diagnostic criteria for 
bronchiolitis obliterans, and made a call for evidence on its website and 
through the specialist Society of Occupational Medicine and a respiratory 
physicians’ reporting network (Appendix 1).
Bronchiolitis obliterans – the disease
Bronchiolitis obliterans is a rare and sometimes severe respiratory 8. 
disease where infl ammation and fi brosis lead to airfl ow limitation in the small 
airways of the lung. The disease can be life-threatening and some patients 
may require lung transplantation. 
Bronchiolitis obliterans is characterised by fi xed airways obstruction, 9. 
whereby bronchioles in the lung become blocked or narrowed by fi brous 
tissue associated with wound healing (granulation). Bronchioles are small 
airways which extend from the larger conducting airways of the bronchi to 
the alveoli (the gas exchanging parts of the lung) (see Figure 1). Patients with 
bronchiolitis obliterans have reduced lung function and typically have dry 
cough, undue shortness of breath upon exertion and occasionally, wheezing. 
Several other respiratory diseases, such as asthma, bronchitis and 10. 
emphysema, have similar clinical symptoms to bronchiolitis obliterans, with 
potential for misclassifi cation. However, a characteristic point of distinction 
between bronchiolitis obliterans and chronic obstructive airways disease is 
the far more rapid onset and time course of symptoms in the former (weeks 
or months and less than a year) in contrast to the slow and insidious onset 
of breathlessness in the latter.
8Diagnosis of bronchiolitis obliterans may involve a variety of test 11. 
modalities – spirometry and other lung function tests, high resolution 
computed tomography (HRCT), chest radiographs and lung biopsy. Affected 
individuals often have severe airways obstruction on spirometry that is 
unresponsive to treatment with bronchodilator medication (fi xed airways 
obstruction). Lung volumes are typically reduced. Chest radiographs may 
show hyperinfl ation in some but not all cases. Due to sampling errors, lung 
biopsies may also appear normal. HRCT is considered the most helpful 
means of diagnosing the disease. Characteristically, this shows a mosaic 
pattern of pulmonary lobules during inspiration, air trapping (hyperinfl ation) 
during expiration, irreversible patchy fi brosis, causing the walls of less 
involved bronchioles to be pulled outwards (so-called ‘traction 
bronchiectasis’), mucus plugging, airway wall thickening and solidifi cation of 
the normally soft, aerated lung tissue (consolidation). 
Figure 1. Diagram of the lungs showing the airways and respiratory zone. Air passes through the trachea, bronchi 
and bronchioles to alveoli which arise from terminal bronchioles. The exchange of oxygen and carbon dioxide 
occurs in the alveoli. Diagram taken from Cotes and Steel, ‘Work related lung disorders’ and reproduced with kind 
permission of Blackwell Scientifi c Publications Ltd.)
Non-occupational causes of bronchiolitis obliterans include viral 12. 
infections, rheumatoid disease, organ transplant rejection and adverse drug 
reactions. Cases of occupational bronchiolitis obliterans have been reported 
in connection with acute exposure to high concentrations of industrial gases, 
including nitrogen dioxide, sulphur dioxide, phosgene, ammonia, chlorine 
and methyl isocyanate (as occurred in the Bhopal disaster in 1984). 
9 The association between bronchiolitis obliterans and chemical agents 13. 
associated with food fl avouring differs from occupational instances in 
paragraph 12 in that cases have developed after exposures occurring from 
routine use of the agents in question, rather than from high concentrations 
arising from accidental chemical spills (in principle, illnesses arising from such 
accidental exposures would fall within the accident provisions of the Scheme). 
Evaluation of the research literature relating to bronchiolitis obliterans
 In May 2000, the National Institute of Occupational Safety and Health 14. 
(NIOSH) in USA was alerted to eight cases of severe airways obstruction in 
workers from a microwave popcorn factory. Five of the cases were on lung 
transplantation lists. An occupational causation was suspected as the 
cluster of cases had severe airways obstruction, occurred at relatively young 
ages (age range 27-51 years; median 41 years), mostly among workers who 
had never smoked or who had all worked in one small plant. The cases were 
employed in the factory for between 1 and 17 years (median duration 2 
years) and none had acute, high chemical concentration exposures before 
the onset of symptoms. The workers reported symptoms after working at 
the factory for a median duration of 1.5 years (range 5 months – 9 years). 
Detailed medical investigations indicated that eight of the cases had 
bronchiolitis obliterans and had had exposures to chemicals involved in the 
fl avouring of microwave popcorn (Akpinar-Elci et al., 2004). A principal 
component of these chemicals is diacetyl, a ketone with butter fl avouring 
characteristics, and it was postulated that diacetyl caused bronchiolitis 
obliterans in these workers (or was a marker for exposure to other closely 
related food fl avouring agents that had a causal relationship to disease). 
Half of the cases had worked in a mixing room where the fl avouring 15. 
components were combined with heated soybean oil and the remainder 
worked in the microwave packaging area. Later hygiene measurements 
suggested that workers in the mixing room were exposed to a geometric 
mean air concentration of diacetyl of 18 parts per million (ppm), and those in 
the microwave packaging area were exposed to 1.3ppm, representing high 
levels of exposure compared with other areas in the factory (0.02ppm). 
The reporting of this case series prompted experimental studies in rats, 16. 
conducted by the Centre for Disease Control (CDC) in North America. These 
added to the biological plausibility of a causal association by showing that 
inhalation of butter fl avourings used at the plant, and diacetyl in particular, 
could cause severe airways damage in animal models (MMWR, 2002). 
Further local investigations followed. A cross-sectional medical and 17. 
hygiene survey at the plant showed that the workforce had an excess 
prevalence of respiratory symptoms compared with a reference population 
(2.6-fold greater prevalence of chronic cough and shortness of breath upon 
10
exertion; 3-fold greater prevalence of wheezing) (Kreiss et al., 2002). The 
relative risks of these symptoms were higher among those who had never 
smoked than in current or former smokers, and were higher amongst 
younger workers (17-39 years) than older workers (40-69 years). The overall 
prevalence of airways obstruction was over 3 times higher than the 
expected rate, and increased by some 8-11 fold in those who had never 
smoked. A strong association was found between estimated cumulative 
exposure to diacetyl and the frequency and extent of airways obstruction. 
Microwave popcorn production workers had higher rates of respiratory 
symptoms than minimally exposed workers who worked in non-fl avoured 
popcorn production, such as offi ce and warehouse areas. Workers who 
mixed the popcorn and fl avour components together in the mixing room 
also had an increased rate of job change attributed to their respiratory 
symptoms. The authors believed that many workers with airways obstruction 
were suffering from bronchiolitis obliterans.
Further cases of bronchiolitis obliterans were reported from other 18. 
fl avouring and food production factories across North America (Kanwal et 
al., 2006; MMWR, 2007), and in fi ve of six microwave popcorn plants 
(including the original plant) investigated by Kanwal et al., evidence was 
found of excesses of respiratory symptoms and fi xed airways obstruction. 
Such symptoms arose this time in the context of apparently low 
concentrations of diacetyl (geometric air concentrations were as low as 
0.02 ppm in mixing rooms with established cases). 
Cases of bronchiolitis obliterans have also been identifi ed in chemical 19. 
workers producing diacetyl for use by food producers in The Netherlands 
(van Rooy et al., 2007). That these recent cases have occurred in diacetyl 
production, rather than in microwave popcorn production, adds strongly 
suggestive evidence that diacetyl (or an agent involved closely in its 
production or use) is a causative agent in the development of bronchiolitis 
obliterans.
Affected workers in index reports have presented with severe airways 20. 
obstruction on spirometry that proved unresponsive to treatment with 
bronchodilator medication. Lung volumes were typically reduced. In affected 
workers from the popcorn factories, the forced expiratory volume in one 
second (FEV1) measurement was only at 17-44% of that expected given 
their age and sex. In affected workers involved in the production of diacetyl, 
FEV1 measurements were 31-42% of predicted values.
The case for prescription
When considering the case for prescription of a disease and its 21. 
occupational exposure, the Council must adhere to statutory requirements 
(see Appendix 2). Briefl y, a disease may only be prescribed if there is a 
11
recognised risk to workers in an occupation, and the link between disease 
and occupation can be established or reasonably presumed in the individual 
case. Where the clinical features of a case are not specifi c to occupation, 
the Council looks for evidence of work causation “on the balance of 
probabilities” (earlier reports explain how this equates in epidemiological 
terms to a more than doubling of risks in the occupational group in 
question). However, in some circumstances attribution is possible on the 
basis of specifi c clinical features of the disease, and more rarely the disease 
only arises from occupation or specifi c occupational activities. One recent 
example in which the Council recommended prescription on the basis of 
clinical features of the disease is extrinsic allergic alveolitis due to exposure 
to mists from metal working fl uid (‘Extrinsic Allergic Alveolitis’ Cm. 6867, 
July 2006). 
Similarly, the case for prescription in bronchiolitis obliterans can be 22. 
made on the basis of specifi c clinical features. The collective evidence on 
this topic suggests that diacetyl, or closely a related food fl avouring, is a 
cause of bronchiolitis obliterans. This view is supported by (i) the clustering 
of cases of this rare disease in close proximity to this shared common 
exposure; (ii) the occurrence of severe respiratory disease of fairly rapid 
onset in the absence of other explanations (e.g. in non-smokers); (iii) the 
dose-response pattern of symptoms and airways obstruction; and (iv) the 
experimental evidence that diacetyl can cause pulmonary damage in animal 
inhalation models. Cases have occurred in workers manufacturing diacetyl 
as well as in those using it as a food fl avouring in popcorn production. This 
strengthens the case that diacetyl itself is the aetiological agent, although 
not excluding the possibility that it is also a marker of exposure to an 
associated causative agent. 
 Given the rarity of this respiratory disease in working populations, 23. 
occurrence of a case in a worker producing diacetyl or employing it in food 
processing and food fl avouring operations is, of itself, strong grounds for 
presuming occupational attribution in the individual case. As outlined in 
paragraph 10, the far more rapid onset and time course of symptoms and 
declining lung function in bronchiolitis provides a point of contrasts with the 
more insidious course of other chronic obstructive pulmonary diseases. 
The disease warrants prescription in that disease can be severely 24. 
disabling, sometimes leading to lung transplantation. Although bronchiolitis 
obliterans may stabilise in some workers who are removed from the 
exposure, in others it may worsen. 
Diagnosis for bronchiolitis obliterans is relatively complicated, due to the 25. 
clinical and pathological overlap with other respiratory conditions such as 
emphysema (Kanwal, 2008). However, it is unlikely that a person will be 
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diagnosed with the condition without having undergone careful hospital 
investigation. It is recommended that confi rmatory evidence of diagnosis be 
sought from the appropriate expert source(s). 
The Council was advised that traditional lung function tests are suitable 26. 
and helpful measures in assessing the disablement arising from bronchiolitis 
obliterans.
Based on the balance of evidence, the Council concludes there is strong 27. 
evidence of an association between work in diacetyl production or use of 
diacetyl as a food fl avouring agent and the development of bronchiolitis 
obliterans. 
Physicians should consider a diagnosis of bronchiolitis obliterans in 28. 
patients presenting with severe fi xed airways obstruction of acute or 
subacute onset and an occupational history of exposure to diacetyl in food 
production or manufacture. 
Prevention
Bronchiolitis obliterans arising from work exposure is a preventable 29. 
illness. The Control of Substances Hazardous to Health Regulations 2002 
(as amended) (COSHH) apply to work with hazardous substances such as 
diacetyl. These regulations require that work is not carried out with any 
substance liable to be hazardous to health unless a suitable and suffi cient 
assessment has been made of the risks created by the work and measures 
are taken to prevent exposure as far as is reasonably practicable. Where it is 
not reasonably practicable to prevent exposures by substitution with a safer 
substance or total enclosure, exposure must be adequately controlled by the 
use of appropriate work processes, systems and engineering controls and 
measures, including local ventilation systems, to control exposures at 
source. Suitable respiratory protective equipment may be used in addition, 
where adequate control cannot otherwise be achieved. Workers handling 
diacetyl need to be informed of the hazards/risks and be provided with 
appropriate training. In addition COSHH requires employers to arrange 
appropriate health surveillance for bronchiolitis obliterans where employees 
are exposed to a substance known to cause it, and there is a reasonable 
likelihood of the disease occurring under the conditions of the work.
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Recommendations
The Council recommends prescription for bronchiolitis obliterans for 30. 
workers involved in diacetyl production or use of diacetyl as a food 
fl avouring agent as shown in the table below.
Prescribed disease Occupation
C31 Bronchiolitis obliterans Work involving the production of 
diacetyl, or the manufacture of food 
fl avourings containing diacetyl, or the 
manufacture of food fl avoured by 
diacetyl .
Diagnosis of bronchiolitis obliterans will normally be based upon 31. 
hospital investigations and confi rmatory evidence of diagnosis should be 
sought from the appropriate expert source(s). 
14
APPENDIX 1: 
Experts consulted 
Dr Chris Stenton (Consultant respiratory physician), University of Newcastle 
Professor David Hendrick (consultant respiratory physician), University of 
Newcastle
Calls for evidence were placed on the IIAC website, with the newsletter of 
the Society of Occupational Medicine UK, and sent to British chest 
physicians through the coordinator of the SWORD national network of 
reporters.
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APPENDIX 2: The Legal Requirements for Prescription
The Industrial Injuries Disablement Benefi t Scheme
The Industrial Injuries Disablement Benefi t (IIDB) scheme provides 32. 
non-contributory, ‘no-fault’ benefi ts for disablement because of accidents or 
prescribed diseases which arise during the course of employed earners’ 
employment. The benefi t is paid in addition to other incapacity and disability 
benefi ts. It is tax-free and administered by the Department for Work and 
Pensions. 
The Role of the Industrial Injuries Advisory Council
IIAC is an independent statutory body established in 1946 to advise the 33. 
Secretary of State for Social Security on matters relating to the IIDB scheme. 
The majority of the Council’s time is spent considering whether the list of 
prescribed diseases for which benefi t may be paid should be enlarged or 
amended. 
The legal requirements for prescription
The Social Security Contributions and Benefi ts Act 1992 states that the 34. 
Secretary of State may prescribe a disease where he is satisfi ed that the 
disease: 
a) ought to be treated, having regard to its causes and incidence and 
any other relevant considerations, as a risk of the occupation and 
not as a risk common to all persons; and
b) is such that, in the absence of special circumstances, the attribution 
of particular cases to the nature of the employment can be 
established or presumed with reasonable certainty.
In other words, a disease may only be prescribed if there is a recognised 35. 
risk to workers in an occupation, and the link between disease and 
occupation can be established or reasonably presumed in individual cases. 
In seeking to address the question of prescription for any particular 36. 
condition, the Council fi rst looks for a workable defi nition of the disease. 
The Council then searches for a practical way to demonstrate in the 
individual case that the disease can be attributed to occupational exposure 
with reasonable confi dence. For this purpose, reasonable confi dence is 
interpreted as being based on the balance of probabilities according to the 
available evidence in the scientifi c literature. An accident at work is 
specifi cally catered for within the IIDB scheme. However, if the condition 
might result from occupational exposure in the absence of an identifi able 
accident, the Council must consider whether it should be included in the list 
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of diseases that are prescribed for benefi t purposes. In these circumstances, 
it may be possible to ascribe a disease to a particular occupational exposure 
in two ways – from specifi c clinical features of the disease or from 
epidemiological evidence that the risk of disease is at least doubled by the 
relevant occupational exposure. 
Clinical features
For some diseases attribution to occupation may be possible from 37. 
specifi c clinical features of the individual case. For example, the proof that 
an individual's asthma is caused by his occupation may lie in its 
improvement when s/he is on holiday and regression when s/he returns to 
work, and in the demonstration that s/he is allergic to a specifi c substance 
with which s/he comes into contact only at work. It can be that the disease 
only occurs as a result of an occupational hazard (e.g. coal workers' 
pneumoconiosis). 
Doubling of risk
Other diseases are not uniquely occupational, and, when caused by 38. 
occupation, are indistinguishable from the same disease occurring in 
someone who has not been exposed to a hazard at work. In these 
circumstances attribution to occupation on the balance of probabilities 
depends on epidemiological evidence that work in the prescribed job, or 
with the prescribed occupational exposure, increases the risk of developing 
the disease by a factor of two or more. In the case of chronic bronchitis and 
emphysema the criteria for prescription were that there needed to be 
evidence of a greater than doubled risk of a disabling loss of lung function in 
exposed compared with unexposed workers. The requirement for, at least, a 
doubling of risk is not arbitrary. It follows from the fact that if a hazardous 
exposure doubles risk, for every 50 cases that would normally occur in an 
unexposed population, an additional 50 would be expected if the population 
were exposed to the hazard. Thus, out of every 100 cases that occurred in 
an exposed population, 50 would do so only as a consequence of their 
exposure while the other 50 would have been expected to develop the 
disease, even in the absence of the exposure. Therefore, for any individual 
case occurring in the exposed population, there would be a 50% chance 
that the disease resulted from exposure to the hazard, and a 50% chance 
that it would have occurred even without the exposure. Below the threshold 
of a doubling of risk only a minority of cases in an exposed population would 
be caused by the hazard and individual cases therefore could not be 
attributed to exposure on the balance of probabilities. The epidemiological 
evidence required should ideally be drawn from several independent studies, 
and be suffi ciently robust that further research at a later date would be 
unlikely to overturn it. 
17
The evidence on bronchiolitis obliterans and occupational exposure to 39. 
diacetyl is such that attribution can be made in the individual case on the 
basis of the clinical features.
18
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